Topics

Tubulis Company Profile

04:51 EDT 16th September 2019 | BioPortfolio

Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. We will advance a range of conjugates, unlimited by indication, using our own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets. For more information, please visit http://tubulis.com.


News Articles [10 Associated News Articles listed on BioPortfolio]

VIDEO: BIO-Europe 2019: Newcomer Tubulis Tackles ADC Technology Shortcomings

Newly established Tubulis has been set up to generate protein-drug conjugates using a novel platform approach deriving from two German...   

VIDEO: BIO-Europe Spring 2019: Newcomer Tubulis Tackles ADC Technology Shortcomings

Newly established Tubulis has been set up to generate protein-drug conjugates using a novel platform approach deriving from two German...   

Tubulis and Glycotope Announce Research and Feasibility Agreement for the Discovery of Antibody Drug Conjugates

Tubulis, a company developing uniquely matched protein drug conjugates, and Glycotope, a clinical-stage immuno-oncology company today announced that they have signed a research and feasibility agreem...

VIDEO: BIO-Europe 2019: Modra Pharmaceuticals CEO On Enhancing Taxanes

Modra Pharmaceuticals’ three goals are to improve the toxicity, the efficacy and the formulation of taxane chemotherapies used to treat...   

Why Novo Holdings Has Invested In ‘Hidden Gem’ Oxford Biomedica

Life sciences investor Novo Holdings buys 10% stake in UK gene therapy biotech.   

Marinomed Marches Towards Approval For Hay Fever Drug

With Budesolv hitting key endpoints in a Phase III allergy trial, the Austrian biotech is stepping up its partnership discussions...   

Novartis' New Oncology CEO Schaffert Has A Potential Blockbuster Launch On Her Hands

In an interview at Novartis' research campus in Cambridge, Mass., Schaffert spoke about the upcoming launch of Piqay for breast...   

Sanofi Genzyme's Sibold On Investing In Blood Disorders And Fending Off Rivals

Sibold talked to Scrip about launching the blood clotting disorder drug Cablivi and finding room in a competitive hemophilia market.   

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Tubulis

Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antibody drug ...

More Information about "Tubulis" on BioPortfolio

We have published hundreds of Tubulis news stories on BioPortfolio along with dozens of Tubulis Clinical Trials and PubMed Articles about Tubulis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tubulis Companies in our database. You can also find out about relevant Tubulis Drugs and Medications on this site too.

Quick Search

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record